Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongqiao Biyan Granules for moderate to severe persistent allergic rhinitis
ChiCTR2100042391Phase 4Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Tongqiao Biyan Granules in allergic rhinitis (AR) (3 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: TNSS. Started Feb 2021; status: recruiting.
02
Drugs
Tongqiao Biyan Granules
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2100042391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042391.